Obesity Treating Neuromodulation System Market Report

Global and Region Obesity Treating Neuromodulation System Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：226
  • REPORT CODE：GMM963253
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Obesity Treating Neuromodulation System market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Obesity Treating Neuromodulation Systemmarket, defines the market attractiveness level of Obesity Treating Neuromodulation System market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Obesity Treating Neuromodulation System industry, describes the types of Obesity Treating Neuromodulation System market, the applications of major players and the market size, and deeply analyzes the current situation of the global Obesity Treating Neuromodulation System market and the development prospects and opportunities of Obesity Treating Neuromodulation System industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Obesity Treating Neuromodulation System market in Chapter 13.

    By Player:

    • Nevro

    • St Jude Medical

    • EnteroMedics

    • Medtronic

    • Nuvectra

    • Leptos Medical

    • Cyberonics

    • BioControl Medical

    By Type:

    • Vagus Nerve Stimulator

    • Splanchnic Nerve Stimulator

    • Deep Brain Stimulator

    • Spinal Cord Stimulator

    • Autonomous Nerve Stimulator

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Ambulatory Surgical Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Obesity Treating Neuromodulation System Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Obesity Treating Neuromodulation System Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Obesity Treating Neuromodulation System Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Obesity Treating Neuromodulation System Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Obesity Treating Neuromodulation System Market Analysis and Outlook to 2022

    • 7.1 Global Obesity Treating Neuromodulation System Consumption (2017-2022)

    • 7.2 United States Obesity Treating Neuromodulation System Consumption (2017-2022)

    • 7.3 Europe Obesity Treating Neuromodulation System Consumption (2017-2022)

    • 7.4 China Obesity Treating Neuromodulation System Consumption (2017-2022)

    • 7.5 Japan Obesity Treating Neuromodulation System Consumption (2017-2022)

    • 7.6 India Obesity Treating Neuromodulation System Consumption (2017-2022)

    • 7.7 South Korea Obesity Treating Neuromodulation System Consumption (2017-2022)

    8 Region and Country-wise Obesity Treating Neuromodulation System Market Analysis and Outlook to 2028

    • 8.1 Global Obesity Treating Neuromodulation System Consumption Forecast (2022-2028)

    • 8.2 United States Obesity Treating Neuromodulation System Consumption Forecast (2022-2028)

    • 8.3 Europe Obesity Treating Neuromodulation System Consumption Forecast (2022-2028)

    • 8.4 China Obesity Treating Neuromodulation System Consumption Forecast (2022-2028)

    • 8.5 Japan Obesity Treating Neuromodulation System Consumption Forecast (2022-2028)

    • 8.6 India Obesity Treating Neuromodulation System Consumption Forecast (2022-2028)

    • 8.7 South Korea Obesity Treating Neuromodulation System Consumption Forecast (2022-2028)

    9 Global Obesity Treating Neuromodulation System Market Outlook by Types and Applications to 2022

    • 9.1 Global Obesity Treating Neuromodulation System Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Vagus Nerve Stimulator Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Splanchnic Nerve Stimulator Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Deep Brain Stimulator Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Spinal Cord Stimulator Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Autonomous Nerve Stimulator Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Obesity Treating Neuromodulation System Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    10 Global Obesity Treating Neuromodulation System Market Outlook by Types and Applications to 2028

    • 10.1 Global Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Vagus Nerve Stimulator Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Splanchnic Nerve Stimulator Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Deep Brain Stimulator Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Spinal Cord Stimulator Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Autonomous Nerve Stimulator Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Obesity Treating Neuromodulation System Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Obesity Treating Neuromodulation System Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Obesity Treating Neuromodulation System Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Obesity Treating Neuromodulation System Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Obesity Treating Neuromodulation System Market Competitive Analysis

    • 14.1 Nevro

      • 14.1.1 Nevro Company Details

      • 14.1.2 Nevro Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Nevro Obesity Treating Neuromodulation System Product and Service

    • 14.2 St Jude Medical

      • 14.2.1 St Jude Medical Company Details

      • 14.2.2 St Jude Medical Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 St Jude Medical Obesity Treating Neuromodulation System Product and Service

    • 14.3 EnteroMedics

      • 14.3.1 EnteroMedics Company Details

      • 14.3.2 EnteroMedics Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 EnteroMedics Obesity Treating Neuromodulation System Product and Service

    • 14.4 Medtronic

      • 14.4.1 Medtronic Company Details

      • 14.4.2 Medtronic Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Medtronic Obesity Treating Neuromodulation System Product and Service

    • 14.5 Nuvectra

      • 14.5.1 Nuvectra Company Details

      • 14.5.2 Nuvectra Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Nuvectra Obesity Treating Neuromodulation System Product and Service

    • 14.6 Leptos Medical

      • 14.6.1 Leptos Medical Company Details

      • 14.6.2 Leptos Medical Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Leptos Medical Obesity Treating Neuromodulation System Product and Service

    • 14.7 Cyberonics

      • 14.7.1 Cyberonics Company Details

      • 14.7.2 Cyberonics Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cyberonics Obesity Treating Neuromodulation System Product and Service

    • 14.8 BioControl Medical

      • 14.8.1 BioControl Medical Company Details

      • 14.8.2 BioControl Medical Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BioControl Medical Obesity Treating Neuromodulation System Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Obesity Treating Neuromodulation System

    • Figure Obesity Treating Neuromodulation System Picture

    • Table Global Obesity Treating Neuromodulation System Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Obesity Treating Neuromodulation System Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Obesity Treating Neuromodulation System Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Obesity Treating Neuromodulation System Consumption by Country (2017-2022)

    • Figure United States Obesity Treating Neuromodulation System Consumption and Growth Rate (2017-2022)

    • Table Europe Obesity Treating Neuromodulation System Consumption and Growth Rate (2017-2022)

    • Figure China Obesity Treating Neuromodulation System Consumption and Growth Rate (2017-2022)

    • Figure Japan Obesity Treating Neuromodulation System Consumption and Growth Rate (2017-2022)

    • Figure India Obesity Treating Neuromodulation System Consumption and Growth Rate (2017-2022)

    • Figure South Korea Obesity Treating Neuromodulation System Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Treating Neuromodulation System Consumption Forecast by Country (2022-2028)

    • Figure United States Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Obesity Treating Neuromodulation System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vagus Nerve Stimulator Consumption and Growth Rate (2017-2022)

    • Figure Global Splanchnic Nerve Stimulator Consumption and Growth Rate (2017-2022)

    • Figure Global Deep Brain Stimulator Consumption and Growth Rate (2017-2022)

    • Figure Global Spinal Cord Stimulator Consumption and Growth Rate (2017-2022)

    • Figure Global Autonomous Nerve Stimulator Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Vagus Nerve Stimulator Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Splanchnic Nerve Stimulator Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deep Brain Stimulator Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Spinal Cord Stimulator Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autonomous Nerve Stimulator Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Obesity Treating Neuromodulation System Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Obesity Treating Neuromodulation System Export by Region (Top 5 Countries) (2017-2028)

    • Table Nevro (Foundation Year, Company Profile and etc.)

    • Table Nevro Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nevro Obesity Treating Neuromodulation System Product and Service

    • Table St Jude Medical (Foundation Year, Company Profile and etc.)

    • Table St Jude Medical Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table St Jude Medical Obesity Treating Neuromodulation System Product and Service

    • Table EnteroMedics (Foundation Year, Company Profile and etc.)

    • Table EnteroMedics Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table EnteroMedics Obesity Treating Neuromodulation System Product and Service

    • Table Medtronic (Foundation Year, Company Profile and etc.)

    • Table Medtronic Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Obesity Treating Neuromodulation System Product and Service

    • Table Nuvectra (Foundation Year, Company Profile and etc.)

    • Table Nuvectra Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nuvectra Obesity Treating Neuromodulation System Product and Service

    • Table Leptos Medical (Foundation Year, Company Profile and etc.)

    • Table Leptos Medical Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Leptos Medical Obesity Treating Neuromodulation System Product and Service

    • Table Cyberonics (Foundation Year, Company Profile and etc.)

    • Table Cyberonics Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cyberonics Obesity Treating Neuromodulation System Product and Service

    • Table BioControl Medical (Foundation Year, Company Profile and etc.)

    • Table BioControl Medical Obesity Treating Neuromodulation System Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioControl Medical Obesity Treating Neuromodulation System Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US